We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
Cap. Flow
+$92M
Cap. Flow %
1.84%
Top 10 Hldgs %
38.84%
Holding
3,762
New
250
Increased
1,451
Reduced
1,277
Closed
224

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$18.4M
2
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$9.77M
3
DYNF icon
BlackRock US Equity Factor Rotation ETF
DYNF
+$5.48M
4
MSFT icon
Microsoft
MSFT
+$4.93M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.9M

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$7.34M
2
SBUX icon
Starbucks
SBUX
+$4.7M
3
CMF icon
iShares California Muni Bond ETF
CMF
+$3.3M
4
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$2.63M
5
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Healthcare 9.68%
3 Financials 7.2%
4 Communication Services 5.16%
5 Consumer Discretionary 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKO.B icon
3151
Embotelladora Andina Series B
AKO.B
$4.95B
$1.09K ﹤0.01%
+45
New +$1.12K
PFS icon
3152
Provident Financial Services
PFS
$3.19B
$1.08K ﹤0.01%
62
– –
LMAT icon
3153
LeMaitre Vascular
LMAT
$1.86B
$1.08K ﹤0.01%
13
+5
+63% +$418
TTGT icon
3154
TechTarget
TTGT
$278M
$1.06K ﹤0.01%
+137
New +$1.09K
AMRX icon
3155
Amneal Pharmaceuticals
AMRX
$5.79B
$1.06K ﹤0.01%
131
– –
NEO icon
3156
NeoGenomics
NEO
$2.13B
$1.05K ﹤0.01%
144
-96
-40% -$775
DNUT icon
3157
Krispy Kreme
DNUT
$577M
$1.04K ﹤0.01%
+358
New +$1.25K
SRDX
3158
DELISTED
Surmodics
SRDX
$1.04K ﹤0.01%
35
-4
-10% -$115
PBMWW
3159
Psyence Biomedical Warrant
PBMWW
$337K
$1.01K ﹤0.01%
+50,000
New +$800
GTX icon
3160
Garrett Motion
GTX
$5.57B
$1.01K ﹤0.01%
96
– –
SUPN icon
3161
Supernus Pharmaceuticals
SUPN
$2.77B
$1.01K ﹤0.01%
32
+20
+167% +$641
RXO icon
3162
RXO
RXO
$3.58B
$1.01K ﹤0.01%
64
-128
-67% -$1.94K
BNDD icon
3163
Quadratic Deflation ETF
BNDD
$20.6M
$1K ﹤0.01%
10
– –
REVG
3164
DELISTED
REV Group
REVG
$999 ﹤0.01%
21
– –
UCTT
3165
Ultra Clean Holdings
UCTT
$3.95B
$993 ﹤0.01%
44
-382
-90% -$7.84K
BGC icon
3166
BGC Group
BGC
$4.89B
$992 ﹤0.01%
97
+40
+70% +$367
REZ icon
3167
iShares Residential and Multisector Real Estate ETF
REZ
$874M
$988 ﹤0.01%
+12
New +$989
FLRN icon
3168
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$2.97B
$987 ﹤0.01%
32
– –
JAMF
3169
DELISTED
Jamf
JAMF
$980 ﹤0.01%
103
– –
XIFR
3170
XPLR Infrastructure LP
XIFR
$1.08B
$980 ﹤0.01%
120
– –
FLJP icon
3171
Franklin FTSE Japan ETF
FLJP
$4.08B
$965 ﹤0.01%
30
– –
NSP icon
3172
Insperity
NSP
$2.01B
$962 ﹤0.01%
16
-333
-95% -$23.3K
KBWY icon
3173
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$311M
$960 ﹤0.01%
61
– –
BLMN icon
3174
Bloomin' Brands
BLMN
$938M
$950 ﹤0.01%
110
-231
-68% -$1.85K
CENT icon
3175
Central Garden & Pet Co
CENT
$2.8B
$950 ﹤0.01%
27
– –
125 126
127
128 129

Similar funds

HFS
Hantz Financial Services Southfield, Michigan $6.56B AUM 16.11% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $6.54B AUM 25.41% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $6.6B AUM 19.75% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Parallel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q2 2025 filing shows 250 new, 1,451 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
  • Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
  • Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
  • Parallel Advisors opened 250 new positions and closed 224 in Q2 2025.
  • Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.